JPRN-UMIN000032400招募中未知
Phase II study exploring reduction method of Lenvatinib for the patients with advanced hepatocellular carcinoma - Lenvatinib reduction study
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 27
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Refractory ascites or pleural effusion, history of hepatic encephalopathy, risky varices; double cancer; metastases to central nervous system; severe complication; pregnant or lactating women, or women of childbearing potential; mental disorder; allergy for Lenvatinib, or contrast agent of CT or/and MRI
研究者
相似试验
已完成
不适用
To Investigate the reduction of craving in patients admitted for the management of alcohol addictioCTRI/2023/02/050153il
招募中
不适用
A phase II study of the dose reduction and shortening of duration of immunosuppressant after HLA-haploidentical transplantation with post-transplantation cyclophosphamide following reduced-intensity conditioninghematologic malignanciesJPRN-UMIN000026002JSCT55
招募中
不适用
A phase II study of the dose reduction and shortening of duration of immunosuppressant after HLA-haploloidentical transplantation with post-transplantation cyclophosphamide following myeloablative conditioninghematologic malignanciesJPRN-UMIN000026001JSCT42
尚未招募
不适用
Validation study for the scheme of reducing the recurrence rate of hepatitis b-related hepatocellular carcinoma in stage I after comprehensive minimally Invasive surgery with traditional Chinese medicine.hepatitis b-related hepatocellular carcinoma in stage IITMCTR1900002320the First Affiliated Hospital of Henan University of TCM
已完成
2 期
Phase II study for evaluation of volume reduction surgery for Stage IV advanced gastric cancer effectively treated with S-1 based combination chemotherapyStageIV gastric cancerJPRN-UMIN000004787PerSeUS-GC40